Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 TrialPeter Bader, Christina Peters, Ulrike Pöetschger et al.|Journal of Clinical Oncology|2015Cited by 132
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trialAnna Eichinger, Michael H. Albert, Ulrike Pöetschger et al.|Leukemia|2022Cited by 26
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALLFlorian Babor, Roland Meisel, Christina Peters et al.|Bone Marrow Transplantation|2019Cited by 21